Drug intelligence / Profile preview

polysporin

Development stage
Unknown
Lead developer
Monarch Pharmaceuticals
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Administration
Topical, Ophthalmic
01

Overview

Polysporin is a topical combination antibiotic ointment or cream containing bacitracin zinc and polymyxin B sulfate as its primary active ingredients. Some formulations (such as Polysporin Complete) may also include gramicidin and lidocaine. Bacitracin acts mainly against gram-positive bacteria by inhibiting bacterial cell wall synthesis through interference with the regeneration of phospholipid carriers involved in peptidoglycan synthesis. Polymyxin B targets gram-negative bacteria by increasing the permeability of the bacterial cell membrane via interaction with membrane phospholipids. The combination provides broad-spectrum antibacterial coverage for minor skin wounds (cuts, scrapes, burns), mild skin infections, and superficial eye infections such as conjunctivitis or blepharitis when used in ophthalmic formulations. It is often recommended for individuals allergic to neomycin[1][2][3][4][5][8].

Brand names
PolysporinPolysporin OphthalmicPolysporin Complete OintmentDouble AntibioticSimply Neosporin
Other names
bacitracin and polymyxin B topicalbacitracin/polymyxin B
02

Targets

C55-PP (Undecaprenyl pyrophosphate)

Beyond the preview

Go deeper on polysporin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polysporin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call